AbbVie (ABBV) announced the U.S. Food and Drug Administration approval of Emblaveo (aztreonam and avibactam). This marks the first ...

AbbVie (ABBV) announced that the U.S. Food and Drug Administration has approved EMBLAVEO, as the first and only fixed-dose, intravenous, ...

NORTH CHICAGO, Ill. - The U.S. Food and Drug Administration (FDA) has approved EMBLAVEO™ (aztreonam and avibactam) for the ...

Make your antibiotic medication as effective as possible by getting these answers before you leave the doctor's office or ...

AbbVie (ABBV) said it has received FDA approval for the combination antibiotic treatment Emblaveo, which was co-developed ...

It's the first and only such therapy approved to fight antimicrobial resistance, or AMR, in bacterial infections.

AbbVie received Food and Drug Administration approval of Emblaveo, an intravenous antibiotic, for treatment of adults with complicated intra-abdominal infections with limited or no treatment options.

The FDA has approved the intravenous antibiotic Emblaveo for adults with complicated intra-abdominal infections who have limited treatment options.

Antibiotics have served as the mainstay of ... treated during the open-labeled phase with a 10-day course of 0.75% metronidazole gel and in which asymptomatic responders were then randomized ...

Metronidazole is added if anaerobic activity ... be redosed if the bariatric surgery exceeds two half-lives of the drug from the time the first dose was administered or if the operation exceeds ...

Researchers reveal that gut microbiota influence the effectiveness of immune checkpoint inhibitors (ICIs) in cancer treatment ...

After hours: February 4 at 5:14:24 PM EST Loading Chart for DRUG ...